期刊文献+

凝血因子的变化与心脑血管疾病相关性 被引量:2

The Relationship Between the Variation of Coagulation Factors and the Cardiovascular,Cerebrovascular Disease
下载PDF
导出
摘要 近年来诸多研究表明,人体内的一些凝血因子或抗凝血蛋白基因多态性与血栓性疾病的发生存在相关性。心脑血管血栓形成造成的心肌梗死(MI)、脑梗死(CI)、冠心病(CHD)等发病率有逐年增多趋势。某些凝血因子的变化也被视为心脑血管疾病的危险因子。根据已有的研究发现,内在凝血途径和外在凝血途径的大部分凝血因子均与心脑血管疾病的发生、发展关系密切。本文对几个成为凝血机制研究热点的纤维蛋白原(Fbg)、组织因子(TF)、凝血因子Ⅶ、Ⅴ及Ⅷ等进行综述。
出处 《血栓与止血学》 2006年第1期34-36,共3页 Chinese Journal of Thrombosis and Hemostasis
  • 相关文献

参考文献26

  • 1[1]WOODWARD M,LOVE GD,RUMLEY A,et al.Fibrinogen as a risk factor for coronary hart disease and mortality in middle-aged men and women.The Scottish heart health study[J].Eur Heart J,1998,19(1) :55-62.
  • 2[2]MONTALESCOT G,COLLER JP,CHOUSSA T,et al.Fibrinogen as a risk factor for coronary heart disease [J].Eur Heart J,1998,19(Suppl):1-7.
  • 3[3]ACEVEDO M,FOODY JM,PEARCE GL,et al.Fibrinogen:associations with cardiovascular events in an outpatient clinic[J].Am Heart J ,2002,143 (2) :277-282.
  • 4何蕴,马丽丽,邢秀萍.进展性脑梗死急性期纤维蛋白原和纤溶指标的动态变化及其意义[J].血栓与止血学,2003,9(3):129-130. 被引量:28
  • 5[7]MARTISHAINEN M,POHJASVAARA T,MIKKELSSON J et al.Fibrinogen gense promoter-455A allele as a risk factor for lacunar stroke[J].Stroke ,2003,34:886-891.
  • 6[8]van der BOM JG,de MAAT MP,BOTS ML,et al.Elevated plasma fibrinogen:cause or consequence of cardiovascular disease[J] ? Arterioscler Thromb Vasc Biol,1998,18(4) :621.
  • 7马会利,葛均波,王颖,黄薇,孙爱军,牛玉宏,方业明,马永莉,冯军,赵洁,王克强.纤维蛋白原及其相关基因β148和β854多态性与冠心病发病的相关性[J].中国动脉硬化杂志,2005,13(3):351-354. 被引量:12
  • 8[10]VERSTEEG HH.Tissue factor as an evolutionary conserved cytokine receptor:implications for inflammation and signal transduction[J].Semin Hematol,2004,41 (Suppl 1):168-172.
  • 9[11]BANAI S,GERTZ SD.Tissue factor as therapeutic target in coronary syndromes[J].Am J Cardiol,2001,87 :763-765.
  • 10[12]OTT I,KOCH W,von BECKERATH N,et al.Tissue factor promotor polymorphism- 630A/G is associated with myocardial infarction[J].Atherosclerosis,2004,177 (1) :189-191.

二级参考文献35

  • 1国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 2魏文宁 郭秀枝.血栓性疾病的诊断和治疗[M].北京:人民卫生出版社,2000.50-65.
  • 3Meade T W, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet,1986, 2: 533-537.
  • 4Thompson S G, Kienast J, Pyke S D M, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group. NEnglJ Med, 1995, 332: 635-641.
  • 5Scarabin P Y, Aillaud M F, Amouyel P, et al. Associations of fibrinogen, factor Ⅷ and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME Study.Prospective epidemiological study of myocardial infarction. Thromb Haemost, 1998, 80: 749-756.
  • 6Rosendaal F R, Siscovick D S, Schwartz S M, et al.Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood, 1997, 89: 2817-2821.
  • 7Rees D C, Cox M, Clegg J B . World distribution of factor V leiden. Lancet, 1995, 346: 1133-1134.
  • 8Kawasaki T, Kaida T, Arnout J, et al. A new animal model of thrombophilia confirms that high plasma factor Ⅷ levels are thrombogenic. Thromb Haemost, 1999,81: 306-311.
  • 9Folsom A R, Wu K K, Rosamond W D, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Circulation, 1997,96: 1102-1108.
  • 10Keenig W. Recent progress in the clinical agents of fibrinogen. Eur Heart J,1995, 16:54-49.

共引文献46

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部